Our data also suggest that pharmacological paradigms aimed to reduce BDNF, or that calpain levels could represent promising strategies to normalise KCC2 levels in the context of prenatal hypoxia, or high risks for the emergence of neurodevelopmental disorders, a medical field where there are little pharmacological preventive approaches. Here, BDNF is linked to neurodevelopmental disorder.